We are proud to formally introduce 2024 Termeer Fellow Nabanita Nawar, PhD, CEO and cofounder of HDAX Therapeutics. A visionary in medicinal chemistry and biotech entrepreneurship, Dr. Nawar has dedicated her career to pioneering groundbreaking therapies that meet critical clinical needs. Under her leadership, HDAX Therapeutics has recently secured an impressive $3.2 million in seed financing to advance its innovative HDAC6-targeting therapeutics. This novel approach aims to transform treatment paradigms for neurological and cardiometabolic diseases, promising significant strides in patient care. Dr. Nawar's accolades include being a Forbes 30 Under 30 honoree and receiving Canada’s prestigious BIOTECanada Next Generation Leadership Award. Her expertise is not only shaping the future of HDAX but also inspiring the next generation of scientists as a lecturer at the University of Toronto. Join us in celebrating Dr. Nawar’s achievements and her commitment to improving patient outcomes through scientific excellence and innovative leadership. #leadership #STEM #TermeerFoundation #HealthcareInnovation #RareDisease #Biotech #Bio #Biotechnology #PatientCare #LifeScience #PeopleEmpoweringCures #ConnectionsEmpoweringCures #LeadershipMatters #Healthcare #Mentorship #Mentor #Science #Leader #CEO #Founder #TermeerFellows
关于我们
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation’s network of emerging and established healthcare innovators cultivates tomorrow’s leaders and leverages their collective?expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, nonprofits, regulatory agencies and other organizations across the global healthcare ecosystem to provide expert?counsel, stimulate innovation, eliminate barriers to progress, and ultimately connect the world of healthcare until every patient has a cure. Together, everything is possible.
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Boston,Massachusetts
- 类型
- 非营利机构
- 创立
- 2017
地点
-
主要
1393 Boylston St
US,Massachusetts,Boston,02215
The Termeer Foundation员工
动态
-
New Web Feature: The Termeer Fellowship Supports Leaders Who Are Making an Impact on Patients Heading up a biotech company goes beyond funding and innovation — it demands leadership driven by values, passion, and a relentless focus on patient outcomes. The Termeer Foundation Fellows Program is designed to nurture these qualities, equipping first-time biotech CEOs with the resources, mentorship, and network they need to build thriving organizations. Through a comprehensive curriculum that spans personal leadership, executive coaching, DEI, and more, the Fellows Program supports biotech leaders in their journey to create life-changing therapies. Since its launch in 2018, the Termeer Fellows Program has empowered 61 fellows with the tools to excel not only as leaders but as individuals. The program’s unique combination of in-person and virtual events, as well as its community-building focus, has fostered a powerful network of biotech leaders. Safia K. Rizvi, CEO of CILA THERAPEUTICS and a 2023 fellow, shares, “The Termeer Fellowship has been a transformative experience, offering me professional growth and a community I can rely on.” Applications for the 2025 Fellowship are now open! If you’re a biotech CEO or know someone who would benefit from this transformative program, we encourage you to apply or share the opportunity with your network. Learn more about the fellowship in our latest web feature. Read the full article at https://lnkd.in/eSt5peJk.
-
Applications for The Class of 2025 Termeer Fellowship are now being accepted. If you're a first-time CEO or founder in the biotech and pharma life science sectors and meet the below criteria, this is your chance to enhance your leadership skills and accelerate your innovative vision. Criteria 1: First-time CEO of an early-stage or non-profit biotech/life science organization ? Criteria 2: Company that is patient focused and identifies as one of the following: ·? Diagnostic ·? Therapeutic ·? Medical device ? Criteria 3: At the time of the application, applicant company’s need to be in one of the following stages (please note, applicants must have secured some seed funding prior to application): ·? Actively raising or successfully raised a seed round ·? Actively raising or successfully raised a Series A ? Apply by November 12 to join a network of visionary leaders dedicated to transforming patient care. Don't miss this transformative opportunity—apply now or share this in your network to support emerging biotech leaders! To learn more about the Termeer Fellowship: https://lnkd.in/e3D67eVU To apply: https://lnkd.in/eacwR58T #leadership #STEM #TermeerFoundation #HealthcareInnovation #RareDisease #Biotech #Bio #Biotechnology #PatientCare #LifeScience #PeopleEmpoweringCures #ConnectionsEmpoweringCures #LeadershipMatters #Healthcare #Mentorship #Mentor #Science #Leader #CEO #Founder #TermeerFellows
-
What an amazing two days in Texas! Catharine Smith, Executive Director of the Termeer Foundation & Erica Mawby-Roche, Senior Director of Programs traveled between Dallas and Houston to connect with mission driven organizations supporting the local biotech start up community and life sciences across Texas. It was an honor to end the trip by attending the Texas Medical Center Innovation Factory's Accelerator for Cancer Therapies investor dinner.? ? This was an incredible opportunity to learn about the remarkable initiatives to foster innovation in life sciences, create new connections and share synergies!? ? A tremendous THANK YOU to Dr. Tinashe Chandauka,?Lydia McClure,?Nicole Small,?Gabby Everett,?Brad Phelan, MBA,?Jun Il Kwun,?Jenny Ligon,?Thomas Luby,?Allison Rhines,?Jennifer Roohi Mueller?!! ? We were thrilled to see some of our Boston partners, Caitlin Reimers Brumme and SueAnn Sheehan in Texas as well!
-
The application for the 2025 Termeer Fellowship will open on September 30. This is your opportunity to join a dynamic and diverse community of biotech leaders dedicated to creating groundbreaking solutions for unmet medical needs. 2023 Termeer Fellow Alvaro Amorrortu, CEO of Mediphage Bioceuticals appreciated his experience and speaks highly of the program: “A fantastic network of a very diverse group of individuals sharing similar goals and objectives, to cure patients. Hearing from different points of view can only help you grow and achieve your goals faster and better. I already feel part of a family.” If you're a first-time CEO (or know someone who is) passionate about making a real difference in healthcare, apply to become part of our prestigious community. Benefit from values-driven leadership programming, mentoring from industry leaders, and a diverse network that spans the globe. #STEM #TermeerFoundation #HealthcareInnovation #RareDisease #Biotech #Bio #Biotechnology #PatientCare #LifeScience #PeopleEmpoweringCures #ConnectionsEmpoweringCures #LeadershipMatters #Healthcare #Mentorship #Mentor #Science #Leader #CEO #Founder #TermeerFellows
-
Last week, Termeer Foundation welcomed the 2024 class of fellows to our Boston headquarters for two enriching days of networking, learning, and growth. The agenda was packed with an expert panel and interactive sessions designed to hone leadership skills and enhance fellows’ effectiveness in building and developing their teams. The two-day session opened with a deep dive into 'Building the Organization' with Termeer mentors: Paul Fonteyne, executive in residence at Canaan Partners; Marie Louise Sveen MD, PhD, head of US R&D Operations at Novo Nordisk; Lydia Meyer-Turkson, board member of Research Bridge Partners; Masako Nakamura, president and COO of Chrysalis Genetics; and Bart Scheerder, business developer at UMCG Innovation Center; moderated by Kyle Peterson, partner and accounting advisory lead at Monomoy Advisors. The discussions were insightful, focusing on creating resilient organizational cultures that thrive on diversity and innovation. Eva Quinn, senior human resources business partner at Higher EQ LLC, led a discussion on culture, hiring, bias, and interviewing. Michèle Barnett Berg, PCC, Envisage Consulting, bridged day one to day two with conversations and activities around creating and leading effective teams, as well as developing ideal team players & feedback. We are immensely proud to support these brilliant minds who are envisioning and actively working to positively impact the future of healthcare. Thank you to our mentors, fellows, and participants for making these sessions a hub of innovative thinking and leadership development. #leadership #STEM #TermeerFoundation #HealthcareInnovation #RareDisease #Biotech #Bio #Biotechnology #PatientCare #LifeScience #PeopleEmpoweringCures #ConnectionsEmpoweringCures #LeadershipMatters #Healthcare #Mentorship #Mentor #Science #Leader #CEO #Founder #TermeerFellows
-
Termeer Foundation team members, Christine Cole and Dan Ouellette, attended last night's Portal Pours event hosted by Portal Innovations, LLC. Huge thank you to Dan Goddard and Tatiana Yglesias Ulloa for putting on a great event! It was amazing to have the Termeer Foundation represented along side impactful organizations like WEST - Women in the Enterprise of Science and Technology, Nucleate, and Latinos in Bio on the panel for Boston Non-Profits Shaping the Future! Can't wait for the next one!
-
Meet Carla Spina PhD, a trailblazer in the biotech field and 2024 fellow of The Termeer Foundation. As Noa Therapeutics Cofounder and CEO, Dr. Spina is at the forefront of developing groundbreaking therapies for inflammatory barrier diseases. Dr. Spina’s journey is nothing short of inspirational. Leveraging an intimate understanding of chronic diseases and her foundational experience at the interface of infectious and inflammatory disease from her PhD in Chemistry at McGill University, Dr. Spina has devoted her career to making a significant impact on patients’ lives. Towards this, Dr. Spina drove the innovation and commercialization of 6 drug-device combinations in over 10 countries globally, led the development of novel therapeutics for infectious disease from concept to clinical trial, and is now pioneering the development of transformational therapeutics for inflammatory barrier diseases as CEO and Cofounder of Noa Therapeutics. Driven to deliver meaningful innovations to address urgent unmet needs and underrepresented patient groups, Noa Therapeutics is revolutionizing treatment for chronic inflammatory diseases involving barrier dysfunction. Tackling heterogenous diseases like atopic dermatitis and ulcerative colitis, Noa is committed to resolving the uniquely dysregulated immune and barrier pathways which underpin these complex diseases. Bringing hope, and the potential for disease modification, to patients struggling with these chronic diseases. ?Under Dr. Spina’s leadership, Noa is not just advancing medical science; it's setting new standards for patient care. As a part of this year's fellowship, Carla will leverage her profound insights and the Termeer network to further her mission of providing groundbreaking, tailored treatments that promise an inclusive safety profile and impactful efficacy. Learn more about Dr. Spina’s work and how The Termeer Foundation mentors leaders like her to create a healthier future at https://lnkd.in/eqNNMUNr. #leadership #STEM #TermeerFoundation #HealthcareInnovation #RareDisease #Biotech #Bio #Biotechnology #PatientCare #LifeScience #PeopleEmpoweringCures #ConnectionsEmpoweringCures #LeadershipMatters #Healthcare #Mentorship #Mentor #Science #Leader #CEO #Founder #TermeerFellows
-
Two Weeks Left to Register for The Termeer Foundation West Coast Meet & Greet! Join us in San Diego on Wednesday, October 9 for an evening at the forefront of biotech innovation! The event is hosted in partnership by The Termeer Foundation and Aquillius. Don't miss your chance to learn about the transformative impact of the Termeer Fellowship and how we empower and support leaders to solve healthcare's toughest challenges. Location: Aquillius, 10918 Technology Place, San Diego, CA Time: 4:00 PM - 7:00 PM With only two weeks left to register, secure your spot today and be part of shaping the future of medicine! Register at https://lnkd.in/esjBjMQQ. #leadership #STEM #TermeerFoundation #HealthcareInnovation #RareDisease #Biotech #Bio #Biotechnology #PatientCare #LifeScience #PeopleEmpoweringCures #ConnectionsEmpoweringCures #LeadershipMatters #Healthcare #Mentorship #Mentor #Science #Leader #CEO #Founder #TermeerFellows
-
Thank you to everyone who made the inaugural CEO & Founder Link event at Cisco Brewers Seaport on Wednesday evening such a huge success! It was an incredible night of networking building, new connections and great conversations with a phenomenal group of biotech leaders. MassBio and The Termeer Foundation launched the CEO & Founder Link earlier this summer. Learn more: https://lnkd.in/eEujUbij Through quarterly engagements like the one this week, we’ll provide leaders with networking, education around key topics, and a peer community with whom they can collaborate. Life sciences company CEOs or founders can apply to join the CEO & Founder Link and attend a future event: https://lnkd.in/eQFDyhr4 Photos courtesy of John Wilcox